AmpliPhi Biosciences Corp (APHB) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 25 transactions totaling $3.8M, demonstrating a bullish sentiment with $3.7M in net insider flow. The most recent transaction on Mar 22, 2018 involved a purchase of 181,820 shares valued at $200.0K.
No significant insider buying has been recorded for APHB in the recent period.
No significant insider selling has been recorded for APHB in the recent period.
Based on recent SEC filings, insider sentiment for APHB is bullish with an Insider Alignment Score of 98/100 and a net flow of $3.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at AmpliPhi Biosciences Corp (APHB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading APHB stock, having executed 25 transactions in the past 90 days. The most active insider is Corp Intrexon (Executive), who has made 1 transactions totaling $2.4M.
Get notified when executives and directors at APHB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 22, 2018 | Curnock Cook Jeremy | Executive | Purchase | 181,820 | $1.10 | $200.0K | |
| Mar 22, 2018 | S. Perry Michael | Executive | Purchase | 181,820 | $1.10 | $200.0K | |
| Dec 8, 2017 | C. Grint Paul | Executive | Award | 599 | $0.62 | $371 | |
| Sep 19, 2017 | Curnock Cook Jeremy | Executive | Purchase | 105,015 | $N/A | $0 | |
| Sep 19, 2017 | S. Perry Michael | Executive | Purchase | 105,015 | $N/A | $0 | |
| Jun 29, 2017 | Curnock Cook Jeremy | Executive | Purchase | 5,757 | $N/A | $0 | |
| Jun 29, 2017 | S. Perry Michael | Executive | Purchase | 5,757 | $N/A | $0 | |
| Dec 29, 2016 | J. Kirk Randal | Executive | Sale | 20,077 | $0.45 | $9.0K | |
| Dec 29, 2016 | J. Kirk Randal | Executive | Sale | 21,923 | $0.45 | $9.9K | |
| Dec 28, 2016 | J. Kirk Randal | Executive | Sale | 44,170 | $0.47 | $20.8K | |
| Dec 28, 2016 | J. Kirk Randal | Executive | Sale | 40,450 | $0.47 | $19.0K | |
| Dec 27, 2016 | J. Kirk Randal | Executive | Sale | 26,308 | $0.51 | $13.4K | |
| Dec 27, 2016 | J. Kirk Randal | Executive | Sale | 24,092 | $0.51 | $12.3K | |
| Dec 9, 2016 | Scott Salka Michael | Executive | Award | 7,000 | $0.39 | $2.7K | |
| Dec 9, 2016 | Robert Martin Steven | Executive | Award | 3,760 | $0.39 | $1.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 14 | $3.7M | 97.7% |
Sale(S) | 6 | $84.4K | 2.2% |
Award(A) | 3 | $4.6K | 0.1% |
Conversion(C) | 2 | $0 | 0.0% |
Insiders at AmpliPhi Biosciences Corp are accumulating shares at an accelerated pace. With 9 insiders making 25 transactions totaling $3.7M in purchases versus $84.4K in sales, the net buying activity of $3.7M signals strong executive confidence. Corp Intrexon (Executive) leads the buying activity with $2.4M in transactions across all time.